
GT Biopharma Inc
GTBP · NASDAQ · Healthcare / Biotechnology
Price History
Full chartMarket Stats
About
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) platforms. It develops GTB-3650, which is in phase 1 trials that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550, that is in phase 1 dose escalation basket trial that targets B7-H3 on the surface of advanced solid tumors;and GTB-7550, a pre-clinical stage product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEOMr. Michael Martin Breen L.L.B.
- Employees1
- Headquarters315 Montgomery Street, San Francisco, CA, United States, 94104, USA
- Websitehttps://www.gtbiopharma.com
Leadership
- Mr. Michael Martin Breen L.L.B.President, CEO & Executive Chairman · b. 1963
- Mr. Alan Louis Urban CPACFO & Secretary · b. 1968
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Buy1
Ownership Breakdown
- Institutions
- 4.66%
- Insiders
- 5.71%
- Retail / Other
- 89.63%
Top Institutional Holders
- Vanguard Capital Management, LLC451.88K1.77%
- Geode Capital Management, LLC294.46K1.15%
- Vanguard Fiduciary Trust Co225.94K0.88%
- Everhart Financial Group, Inc.100.00K0.39%
- SRS Capital Advisors Inc93.63K0.37%
- Opal Wealth Advisors, LLC81.81K0.32%
- Seacrest Wealth Management, LLC50.10K0.20%
- KITCHING PARTNERS LLC50.00K0.20%
- UBS Group AG45.97K0.18%
- Integrated Wealth Concepts LLC40.01K0.16%
- TWO SIGMA SECURITIES, LLC31.80K0.12%
- LPL Financial Corp30.38K0.12%
- Invst LLC23.40K0.09%
- Advisor Group Holdings, Inc.21.00K0.08%
- BlueCreek Investment Partners, LLC20.77K0.08%
- HPM Partners LLC20.02K0.08%
- CI Private Wealth LLC20.00K0.08%
- Private Wealth Management Group LLC20.00K0.08%
Top Fund Holders
- Fidelity Extended Market Index168.03K0.66%
- Fidelity Series Total Market Index61.94K0.24%
Stock Splits
- Sep 8, 20261:25
- Feb 5, 20241:30
- Feb 11, 20211:17